🔎 Trials Near Me

Beranda › Penyakit Sel Sabit › Distrik Columbia › Washington

Uji klinis Penyakit Sel Sabit di Washington, DC

20 studi untuk Penyakit Sel Sabit mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03937817

Blood Sampling for Research Related to Sickle Cell Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT00542230

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Menerima pesertaFase 3
  • Childrens National Hospital, Washington D.C.
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06439082

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Menerima pesertaFase awal 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06313398

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

Menerima pesertaStudi observasional
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05170412

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05904093

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Menerima pesertaFase 3
  • Childrens National Medical Ctr, Washington D.C.
  • MedStar Hlth Res Institute, Washington D.C.
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06612268

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Menerima pesertaStudi observasional
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06944067

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

Menerima pesertaFase 1
  • National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06442761

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Menerima pesertaFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 4 hingga 65 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07599176

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07566494

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Menerima pesertaStudi observasional
  • Georgetown University, Washington D.C.
  • Children's National Hemophilia Center, Washington D.C.
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Menerima pesertaFase 2
  • Center for Cancer and Blood Disorders, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360

Cooperative Assessment of Late Effects for SCD Curative Therapies

Menerima pesertaStudi observasional
  • Children's National Medical Center, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 4 hingga 65 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Menerima pesertaStudi observasional
  • Children's National Hospital (MRD-HCT), Washington D.C.
Usia 3 hingga 20 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06941389

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Menerima pesertaFase 2
  • Children's National Hospital, Washington D.C.
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06635902

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Menerima pesertaFase 2
  • Children's National Health System, Washington D.C.
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT03587272

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Menerima pesertaFase 2
  • Children's National Hospital, Washington D.C.
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 26 Sep 2025 · NCT06358638

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

Menerima peserta
  • Children's National Hospital, Washington D.C.
Usia 7 hingga 16 · Semua jenis kelamin · Diperbarui 13 Feb 2025 · NCT06770010

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Menerima peserta
  • Children's National Hospital, Washington D.C.
Usia 8 hingga 16 · Semua jenis kelamin · Diperbarui 10 Jan 2025 · NCT05099874

Uji klinis Penyakit Sel Sabit di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.